home / stock / pgen / pgen news


PGEN News and Press, Precigen Inc. From 04/18/23

Stock Information

Company Name: Precigen Inc.
Stock Symbol: PGEN
Market: NASDAQ
Website: precigen.com

Menu

PGEN PGEN Quote PGEN Short PGEN News PGEN Articles PGEN Message Board
Get PGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

PGEN - 3 High-Growth Biotech Stocks Poised for Success in 2023

2023-04-18 06:40:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors look for growth opportunities wherever they can find them. If that describes you, then there are some high-growth biotech stocks that could present an opportunity. ...

PGEN - Precigen Presents Preclinical Data for the Next Generation Mesothelin UltraCAR-T® with Intrinsic PD-1 Blockade at the AACR Annual Meeting 2023

Precigen Presents Preclinical Data for the Next Generation Mesothelin UltraCAR-T® with Intrinsic PD-1 Blockade at the AACR Annual Meeting 2023 PR Newswire – First preclinical data presented for the next generation of the UltraCAR-T platform utilizing a mesothelin (...

PGEN - Precigen regains exclusive rights to CAR-T treatment for cancer

2023-04-03 16:48:12 ET Precigen ( NASDAQ: PGEN ) amended its exclusive license agreement with Alaunos Therapeutics to use UltraCAR-T platform for development and commercialization of two CAR-T targets, CD19 and B-cell maturation antigen, in order to bolster portfolio and...

PGEN - Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T®

Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T® PR Newswire – Precigen amends exclusive license agreement with Alaunos to bolster portfolio and broaden strategic o...

PGEN - Precigen stock jumps ~10% as CAR-T cell therapy's dosing starts in cancer trial

2023-03-29 12:30:01 ET Precigen ( NASDAQ: PGEN ) stock rose ~12% on Wednesday after the company said that the first patient was dosed in a phase 1/1b trial of PRGN-3007 to treat advanced ROR1-positive (ROR1 + ) blood and solid tumors. The target population for...

PGEN - Precigen Announces Further Advancement of UltraCAR-T® Platform with First Patient Dosed in Phase 1/1b Dose Escalation/Dose Expansion Study of PRGN-3007 in Advanced ROR1+ Hematological and Solid Tumors

Precigen Announces Further Advancement of UltraCAR-T® Platform with First Patient Dosed in Phase 1/1b Dose Escalation/Dose Expansion Study of PRGN-3007 in Advanced ROR1+ Hematological and Solid Tumors PR Newswire – Milestone represents the first patient dosed with ...

PGEN - Precigen to Participate in a Virtual Fireside Chat at Cantor's "The Future of Oncology" Virtual Symposium

Precigen to Participate in a Virtual Fireside Chat at Cantor's "The Future of Oncology" Virtual Symposium PR Newswire GERMANTOWN, Md. , March 28, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development o...

PGEN - Precigen eases fears of exposure to Silicon Valley Bank crisis

2023-03-13 06:34:29 ET Precigen ( NASDAQ: PGEN ) disclosed in a SEC filing on Monday that it has "minimal exposure" to Silicon Valley Bank (SVB), which failed Friday and was closed down by California . Despite the bank's closure, the biotechnology company reaffirmed it...

PGEN - CARA and DOMO among mid-day movers

2023-03-07 12:39:41 ET Gainers: ThredUp ( TDUP ) +73% . WW International ( WW ) +49% . Unicycive ( UNCY ) +39% . Protagonist Therapeutics ( PTGX ) +32% . Bionomics ( BNOX ) +28% . Novo Integrated Sciences ( NVOS ) +25% ...

PGEN - 5 Penny Stocks To Buy According To Analysts, Targets Up To 952%

2023-03-07 11:35:38 ET Jerome Powell takes center stage today and tomorrow with his semiannual testimony. While it has brought plenty of volatility to the stock market, some asset classes are generally experiencing a bit more as a result. I’m talking about penny stocks and there ...

Previous 10 Next 10